Knee Lesions on MRI Likely to Worsen Into OAKnee Lesions on MRI Likely to Worsen Into OA
Knee lesions likely to develop into symptomatic osteoarthritis were identifiable as MRI changes in nonsymptomatic but high-risk subjects. Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 6, 2015 Category: Rheumatology Tags: Rheumatology News Source Type: news
American College of Rheumatology (ACR) 2015 Annual MeetingAmerican College of Rheumatology (ACR) 2015 Annual Meeting
Read clinically focused news coverage of key developments from ACR 2015. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 2, 2015 Category: Rheumatology Tags: Conference Coverage Source Type: news
Martin Luther King Jr's Struggle With Mental IllnessMartin Luther King Jr's Struggle With Mental Illness
Dr Nassir Ghaemi explains how the civil rights icon's despair may have also served as the source of his greatness. Medscape Psychiatry (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 26, 2015 Category: Rheumatology Tags: Psychiatry Expert Column Source Type: news
Obama Plan for Opioid Abuse Stresses Prescriber TrainingObama Plan for Opioid Abuse Stresses Prescriber Training
The new initiative also encourages the use of buprenorphine and other forms of medication-assisted treatment for prescription drug abuse. Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 23, 2015 Category: Rheumatology Tags: Internal Medicine News Source Type: news
FDA Declines to Expand Approval of Pfizer Arthritis Drug XeljanzFDA Declines to Expand Approval of Pfizer Arthritis Drug Xeljanz
U.S. health regulators declined to approve Pfizer Inc's oral rheumatoid arthritis drug Xeljanz (tofacitinib) to treat moderate to severe cases of plaque psoriasis, the drugmaker said on Wednesday. Reuters Health Information (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 15, 2015 Category: Rheumatology Tags: Rheumatology News Source Type: news
An Important Consideration in Ankylosing Spondylitis An Important Consideration in Ankylosing Spondylitis
Dr Jonathan Kay talks about indication and treatment discrepancies on the ankylosing spondylitis spectrum, saying that some back pain patients end up excluded from some effective treatments. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 25, 2015 Category: Rheumatology Tags: Rheumatology Commentary Source Type: news
Joint Pain, Inflammation, and a Caribbean Vacation: A CaseJoint Pain, Inflammation, and a Caribbean Vacation: A Case
Dr Paget discusses a recent patient of his who returned from a cruise in the Caribbean with severe joint pain and inflammation. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 15, 2015 Category: Rheumatology Tags: Rheumatology Commentary Source Type: news
Biosimilars: Unanswered QuestionsBiosimilars: Unanswered Questions
Dr Paget discusses the potential impact of biosimilars in rheumatology and some of the unanswered questions about their use. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 7, 2015 Category: Rheumatology Tags: Rheumatology Commentary Source Type: news
Understanding, Diagnosing, and Treating Sjogren SyndromeUnderstanding, Diagnosing, and Treating Sjogren Syndrome
Dr Fox reports on the 13th International Symposium on Sjogren's Syndrome and shares his perspective on advances in the field. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 31, 2015 Category: Rheumatology Tags: Rheumatology Expert Column Source Type: news
Comedication in Spondylitis and Anti-TNF RetentionComedication in Spondylitis and Anti-TNF Retention
Dr Deane reviews and comments on a study evaluating the potential effect of comedication with conventional DMARDs on retention of anti-TNF agent use in spondylitis. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 17, 2015 Category: Rheumatology Tags: Rheumatology Viewpoint Source Type: news
Secukinumab Effective for Treating Psoriatic ArthritisSecukinumab Effective for Treating Psoriatic Arthritis
The anti-interleukin-17A monoclonal antibody secukinumab improves signs and symptoms in patients with psoriatic arthritis, according to results from Novartis' FUTURE 2 trial. Reuters Health Information (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 13, 2015 Category: Rheumatology Tags: Rheumatology News Source Type: news
Identifying Patients for Reducing Anti-TNF Therapy Identifying Patients for Reducing Anti-TNF Therapy
Dr Deane reviews a recent study describing the use of clinical and ultrasonographic assessment to identify patients who are potential candidates for reduction of anti-tumor necrosis factor therapy. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 12, 2015 Category: Rheumatology Tags: Rheumatology Viewpoint Source Type: news
Cancer Risk Factors in Patients With Scleroderma Cancer Risk Factors in Patients With Scleroderma
Dr Deane reviews and comments on a recent study evaluating whether demographics and clinical features, such as autoantibody status, are risk factors for cancer in patients with scleroderma. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 15, 2015 Category: Rheumatology Tags: Rheumatology Viewpoint Source Type: news
European League Against Rheumatism (EULAR) Congress 2015European League Against Rheumatism (EULAR) Congress 2015
Read clinically focused news coverage of key developments from EULAR 2015. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 12, 2015 Category: Rheumatology Tags: Conference Coverage Source Type: news
6 Biosimilar Questions Answered 6 Biosimilar Questions Answered
Dr Steven Feldman offers a brief overview of the increasing role of biosimilar medications in treating inflammatory disease. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 5, 2015 Category: Rheumatology Tags: Rheumatology Expert Column Source Type: news
